← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Rxi Pharmaceuticals Corporation
Marlborough, MA
$1,467,743
Total funding
4
Grants
Funding over time
peak $876.9K · FY2010–12$1M$750K$500K$250K$0
'10
'11
'12
Funding mix
By agency
NIH$1,467,743 · 4
By mechanism
R43$1,467,743 · 4
Investigators at Rxi Pharmaceuticals Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Novel RNAi therapy for ALS and other Neurodegenerative Disorders$304,559
R43 · FY2011 · NS
Orally administered anti-TNFalpha RNAi therapeutic for autoimmune disorders$298,544
R43 · FY2010 · AI
Orally administered anti-TNFalpha RNAi therapeutic for autoimmune disorders$298,544
R43 · FY2011 · AI
Development of sd-rxRNAs as Therapy for Retinoblastoma and Other Malignancies$292,272
R43 · FY2012 · CA
Improving self delivering properties of RNAi compounds through medicinal chemistr$273,824
R43 · FY2011 · GM